Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1

• Eriko Isogai,

  Affiliations Division of Biochemistry and Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba, Japan, Laboratory of Cancer Genomics, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba, Japan

  ⨯
• Miki Ohira,

  Affiliation Laboratory of Cancer Genomics, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba, Japan

  ⨯
• Toshinori Ozaki,

  Affiliation Laboratory of Anti-Tumor Research, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba, Japan

  ⨯
• Shigeyuki Oba,

  Affiliation Integrated Systems Biology Laboratory, Department of Systems Science, Graduate School of Informatics, Kyoto University, Gokasho, Uji, Kyoto, Japan

  ⨯
• Yohko Nakamura,

  Affiliation Division of Biochemistry and Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba, Japan

  ⨯
• Akira Nakagawara

  * E-mail: akiranak@chiba-cc.jp

  Affiliation Division of Biochemistry and Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chuoh-ku, Chiba, Japan

  ⨯